NCT01369940 is a clinical trial in Fetal Growth Restriction, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

What condition does NCT01369940 study?

NCT01369940 studies Fetal Growth Restriction, Growth Discordancy.

Is NCT01369940 still recruiting?

NCT01369940 is currently completed. Last updated 5 September 2017.

Last reviewed 2017-09-05 · How we verify

NCT01369940

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The NICHD Fetal Growth Study: Twin Gestations

Completed Last updated 5 September 2017

What this trial tests

trial in Fetal Growth Restriction in 171 participants. Completed in 30 September 2014.

Timeline

29 May 2011

Primary endpoint
25 August 2013

30 September 2014

Quick facts

Lead sponsor	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	171
Start date	29 May 2011
Primary completion	25 August 2013
Estimated completion	30 September 2014
Sites	9 locations across United States

Conditions studied

Fetal Growth Restriction — all drugs for Fetal Growth Restriction →
Growth Discordancy — all drugs for Growth Discordancy →

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Who can join

Adults 18 to 45, female only, with Fetal Growth Restriction or Growth Discordancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Normal growth and development of twins are important for the long-term health of the children. The purpose of this study was to empirically define the trajectory of fetal growth in dichorionic twins using longitudinal two-dimensional ultrasonography and to compare the fetal growth trajectories for dichorionic twins with those based on a growth standard developed by our group for singletons. This knowledge may lead to interventions that could minimize or prevent pregnancy and newborn health problems in the future.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intrauterine growth discordance across gestation and birthweight discordance in dichorionic twins.
Amyx MM, Albert PS, Bever AM, Hinkle SN, et al · · 2020 · cited 14× · PMID 31454510 · DOI 10.1016/j.ajog.2019.08.027

Verify or expand the search:

Other recruiting trials for Fetal Growth Restriction

Currently open trials in the same condition.

NCT06919692 — Maternal Left Lateral Position in Fetal Growth Restriction · NA · recruiting
NCT07015203 — The Combined First Trimester Screening · recruiting
NCT06497959 — Study of Placental Vascularization Using Contrast Ultrasound · Phase 3 · recruiting
NCT05674487 — Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN) · NA · recruiting
NCT06372938 — Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach · active not recruiting

Other Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) trials

Trials by the same sponsor.

NCT07502586 — Turner Syndrome: Genetic Considerations · recruiting
NCT07357701 — Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI) · recruiting
NCT06851754 — Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency · Phase 3 · recruiting
NCT05548881 — Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnan · withdrawn
NCT06749366 — Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01369940 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Last refreshed: 5 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01369940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing